| Title | Date | PubMed ID |
|---|
| Inhibition of indoleamine 2,3-dioxygenase activity by fatty acids and prostaglandins: A structure function analysis. | 2017 Jul | 28735627 |
| Substrate binding in human indoleamine 2,3-dioxygenase 1: A spectroscopic analysis. | 2017 Apr | 28189796 |
| Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions. | 2017 Jan 27 | 28011425 |
| Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway. | 2017 Jan | 27930920 |
| Kynurenine pathway metabolites and enzymes involved in redox reactions. | 2017 Jan | 26970015 |
| Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells. | 2016 Nov | 27667153 |
| Structural Study of a Flexible Active Site Loop in Human Indoleamine 2,3-Dioxygenase and Its Functional Implications. | 2016 May 17 | 27112409 |
| Substrate Oxidation by Indoleamine 2,3-Dioxygenase: EVIDENCE FOR A COMMON REACTION MECHANISM. | 2015 Dec 25 | 26511316 |
| Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening. | 2015 Oct 8 | 26348881 |
| Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells. | 2015 Oct | 26147366 |